Jeffrey Jones
MD, MPH
Clinical Development Leader, Hematology
👥Biography 个人简介
Jeffrey Jones contributed to pivotal venetoclax registration trials in relapsed and 17p-deleted chronic lymphocytic leukemia. His clinical work established early efficacy signals that supported accelerated approval. He continues to lead hematology clinical development programs advancing BCL-2 family targeting.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Jeffrey Jones 的研究动态
Follow Jeffrey Jones's research updates
留下邮箱，当我们发布与 Jeffrey Jones（AbbVie / formerly Ohio State University）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment